• SENSEX 74,525.19
    -256.57 (--0.34%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Solar Industries
    19,450.15 11,641.10(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • TCS
    2,322.50 3,336.70(%)
  • Reliance Industries
    1,249.00 1,250.55(%)
  • Pine Labs
    191.50 134.75(%)
  • Netweb Technol.
    4,675.00 2,820.80(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,882.00 1,575.00(%)
  • SBI
    979.00 816.25(%)
  • Bharat Electron
    387.65 380.35(%)
  • Coforge
    1,780.00 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • IFCI
    77.80 46.20(%)
  • Molbio Diagnosti
    1,274.05 925.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Balaxi Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 22472.0
  • ISIN : INE618N01022
23.39 0 (0.65%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    22.75

  • Today’s High

    24.69

  • Open

    23.40

  • Perv Close

    23.24

  • 52W Low

    15.20

  • 52W High

    47.71

Key Indicators

  • P/E(TTM)

    34.91

  • Mar.Cap (₹Cr.)

    129.13

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.09

  • Debt-Equity Ratio

    0.65

  • AGM Date

    11-Sep-2026

  • EPS

    0.67

  • P/E Ratio

    34.91

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    129.13

  • RONW (%)

    -25.94

  • ROCE (%)

    20.69

Score Board

  • Equity (₹ in Cr.)

    11.04

  • BV (₹)

    24.10

  • Sales( ₹ in Cr.)

    80.85

  • NP (in Cr.)

    5.15

  • NP Var(%)

    43.0

  • Div%

    0.0

  • CPS (₹)

    1.10

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    129.13

  • 52 Week High

    47.71

  • 52 Week Low

    15.20

  • Price BSE

    0.0

  • Price NSE

    23.00

  • Market Capital( in Cr.)

    129.13

  • P/C Ratio

    21.70

  • P/E Ratio

    24.70

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 60.99 70.20 108.14 101.29 86.87 45.63
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 60.99 70.20 108.14 101.29 86.87 45.63
Other Income 5.37 2.40 6.60 2.75 1.81 0.59
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 66.36 72.60 114.74 104.04 88.68 46.22
EXPENDITURE :            
Raw Materials 50.94 56.49 82.10 76.92 63.33 32.83
Power and Fuel Cost 0.04 0.04 0.04 0.02 0.00 0.00
Employee Cost 4.87 5.04 4.04 2.90 1.95 1.75
Other Manufacturing Expenses 0.24 0.21 0.25 0.13 0.12 0.00
Selling and Administration Expenses 1.97 2.58 4.51 3.79 2.06 1.71
Miscellaneous Expenses 0.32 0.49 0.33 0.23 0.39 0.69
Employee Benefit Expenses 4.87 5.04 4.04 2.90 1.95 1.75
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 58.38 64.84 91.27 83.99 67.85 36.99
Operating Profit 7.98 7.75 23.48 20.05 20.83 9.24
Interest 2.24 1.66 0.51 0.10 0.15 0.05
Gross Profit 5.74 6.09 22.97 19.95 20.68 9.19
Depreciation 0.46 0.51 0.52 0.25 0.09 0.01
Profit Before Tax 5.28 5.58 22.45 19.70 20.59 9.18
Current Tax 1.78 2.04 5.17 5.00 5.46 2.69
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.10 -0.11 1.06 0.03 0.00 0.00
Reported Net Profit 3.60 3.65 16.22 14.67 15.13 6.50
Extraordinary Items 0.00 -0.04 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.60 3.69 16.22 14.67 15.13 6.50
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 55.99 52.34 36.61 21.95 6.81 0.32
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.50 0.00 0.00 0.00
P & L Balance carried down 59.59 55.99 52.34 36.61 21.95 6.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 5.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.50 0.00 0.00
Earnings Per Share-Unit Curr 0.65 0.67 15.93 14.67 15.13 6.50
Earnings Per Share(Adj)-Unit Curr 0.65 0.13 3.19 2.93 3.03 1.30
Book Value 23.16 21.61 80.35 57.91 43.25 28.11
Book Value(Adj)-Unit Curr 23.16 4.32 16.07 11.58 8.65 5.62

Shareholding Pattern

  • Promoter Group

    65.99%

  • Public Share Holding

    34.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,000,000 63.40 35,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,431,770 2.59 1,431,770 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,431,770 65.99 36,431,770 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,160 0.02 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26 0.00 26 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,400,537 2.54 1,400,537 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,413,723 2.56 1,400,563 3
2] Non Institution
Bodies Corporate 424,566 0.77 424,566 44
Clearing Members 50 0.00 50 1
Directors of their Relatives 1,068,795 1.94 1,068,795 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 603,597 1.09 603,597 128
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 613,371 1.11 613,371 177
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,122,612 5.66 3,122,612 11
Individuals holding nominal share capital up to Rs. 1 lakh 10,362,260 18.77 10,224,810 14,311
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,166,756 2.11 1,166,756 2
Sub Total 17,362,007 31.45 17,224,557 14,676
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 55,207,500 100.00 55,056,890 14,682

Company Background

Balaxi Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Balaxi Pharmaceuticals Ltd
  • BSE Code : 22472.0
  • ISIN : INE618N01022

  • Incorporation Year

    1942

  • Registered Office

    41/298-D2 2nd Flr Saniya Plaza
    Mahakavi Bharatiyar Road, Cochin,
    Kerala-682035

  • Telephone

    91-484-4032952/6596725

  • FAX

  • Chairman

  • Managing Director

    Ashish Maheshwari

  • Company Secretary

    Mohith Kumar Khandelwal

  • Auditor

    P Murali & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    SKDC Consultants Ltd
    Surya 35 Mayflower ,
    Avenue Sowripalayam ,Road
    Mumbai - Coimbatore - 641 028

Balaxi Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Balaxi Pharma 23.39 66.36 60.99 34.91 5.06
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77